Futura Medical (FUM) - Total Liabilities
Based on the latest financial reports, Futura Medical (FUM) has total liabilities worth GBX2.44 Million GBX (≈ $297.00 USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Futura Medical cash conversion from operations to assess how effectively this company generates cash.
Futura Medical - Total Liabilities Trend (2001–2024)
This chart illustrates how Futura Medical's total liabilities have evolved over time, based on quarterly financial data. Check Futura Medical (FUM) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Futura Medical Competitors by Total Liabilities
The table below lists competitors of Futura Medical ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Anemoi International Ltd
LSE:AMOI
|
UK | GBX220.87K |
|
Unicorn Mineral Resources PLC
LSE:UMR
|
UK | GBX374.10K |
|
Premier African Minerals Ltd
LSE:PREM
|
UK | GBX60.88 Million |
|
Sonder Holdings Inc
NASDAQ:SOND
|
USA | $1.49 Billion |
|
Physiomics Plc
LSE:PYC
|
UK | GBX165.00K |
|
Gaming Technologies Inc. Common Stock
NASDAQ:GMGT
|
USA | $5.17 Million |
|
FAT Brands Inc
NASDAQ:FATBW
|
USA | $1.79 Billion |
|
BSF Enterprise Plc
LSE:BSFA
|
UK | GBX289.02K |
Liability Composition Analysis (2001–2024)
This chart breaks down Futura Medical's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Futura Medical worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.92 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.80 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.44 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Futura Medical's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Futura Medical (2001–2024)
The table below shows the annual total liabilities of Futura Medical from 2001 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | GBX4.63 Million ≈ $563.01 |
-27.01% |
| 2023-12-31 | GBX6.34 Million ≈ $771.34 |
+261.62% |
| 2022-12-31 | GBX1.75 Million ≈ $213.30 |
-15.64% |
| 2021-12-31 | GBX2.08 Million ≈ $252.85 |
+171.12% |
| 2020-12-31 | GBX766.52K ≈ $93.26 |
-84.19% |
| 2019-12-31 | GBX4.85 Million ≈ $589.80 |
+139.32% |
| 2018-12-31 | GBX2.03 Million ≈ $246.45 |
+305.80% |
| 2017-12-31 | GBX499.14K ≈ $60.73 |
-41.63% |
| 2016-12-31 | GBX855.18K ≈ $104.05 |
+17.29% |
| 2015-12-31 | GBX729.12K ≈ $88.71 |
+19.94% |
| 2014-12-31 | GBX607.89K ≈ $73.96 |
+27.17% |
| 2013-12-31 | GBX478.00K ≈ $58.16 |
+42.71% |
| 2012-12-31 | GBX334.95K ≈ $40.75 |
+72.66% |
| 2011-12-31 | GBX194.00K ≈ $23.60 |
+27.63% |
| 2010-12-31 | GBX152.00K ≈ $18.49 |
-32.14% |
| 2009-12-31 | GBX224.00K ≈ $27.25 |
+47.37% |
| 2008-12-31 | GBX152.00K ≈ $18.49 |
-51.75% |
| 2007-12-31 | GBX315.00K ≈ $38.33 |
+33.47% |
| 2006-12-31 | GBX236.00K ≈ $28.71 |
-0.42% |
| 2005-12-31 | GBX237.00K ≈ $28.84 |
+5.33% |
| 2004-12-31 | GBX225.00K ≈ $27.38 |
+25.00% |
| 2003-12-31 | GBX180.00K ≈ $21.90 |
-27.13% |
| 2003-01-31 | GBX247.00K ≈ $30.05 |
-5.73% |
| 2002-01-31 | GBX262.00K ≈ $31.88 |
-58.41% |
| 2001-01-31 | GBX630.00K ≈ $76.65 |
-- |
About Futura Medical
Futura Medical plc research, develops, and commercializes pharmaceutical and healthcare products for sexual health. The company's lead product includes Eroxon, a topical gel for the treatment of erectile dysfunction. It also develops WSD4000 for the treatment of sexual dysfunction in women. The company operates in the United Kingdom, the European Union, the United States, and internationally. Fut… Read more